Trial Profile
A phase I study of ABT 510 and concurrent radiotherapy for patients with newly diagnosed glioblastoma multiforme
Status:
Not stated
Phase of Trial:
Phase I
Latest Information Update: 31 Jul 2007
Price :
$35
*
At a glance
- Drugs ABT 510 (Primary)
- Indications Glioblastoma
- Focus Adverse reactions
- 31 Jul 2007 New trial record.